The diagnostic value of urine proteomics in interstitial lung disease
10.3760/cma.j.cn114452-20240227-00099
- VernacularTitle:尿液蛋白质组学对间质性肺病诊断价值
- Author:
Lilong WEI
1
;
Yun ZHOU
;
Liwei WANG
;
Qingwan SONG
;
Zhengguang GUO
;
Yongtong CAO
Author Information
1. 中日友好医院检验科，100029 北京
- Keywords:
Lung diseases, interstitial;
Urine proteomics;
Disease markers
- From:
Chinese Journal of Laboratory Medicine
2024;47(10):1159-1168
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the diagnostic value of urine proteomics in interstitial lung disease.Methods:A case control study was conducted. 10 patients (age 56.70±14.78 years) with interstitial lung disease, 9 patients (age 51.30±23.26 years) with pulmonary infection and 10 healthy controls (age 50.20±6.07 years) from the physical examination center were selected from China-Japan Friendship Hospital from March 12 to April 15, 2023. The urine proteomics of three groups of people were studied using Liquid chromatography-mass spectrometry proteomics technology. Based on Data-Independent Acquisition mass spectrometry quantitative technology, three groups of people were compared, and t-test was performed between groups and relevant functional analysis was conducted.Results:A total of 2 730 proteins were identified. Three groups of people can be clearly distinguished by urine proteome using partial least squares discriminant analysis based on orthogonal signal correction. Quantitative comparison of proteins was conducted by the screening criteria for differential proteins with P<0.05 and protein abundance fold changes of>3/2 or<2/3. 49 proteins between interstitial lung disease patients and healthy people, as well as 57 proteins between interstitial lung disease patients and infectious diseases patients, were significantly changed. ECM receptor interaction and complement-coagulation cascade pathways were enriched by GO enrichment and KEGG analysis on differentially expressed proteins. Conclusions:Urinary proteomics can effectively distinguish patients with interstitial lung disease from those with pulmonary infections and the normal population. The differential proteins identified in this experiment have certain diagnostic performance (AUC value 0.68-1.00) and can be used as potential disease markers for the diagnosis of interstitial lung disease.
